1. Home
  2. MRSN vs BWEN Comparison

MRSN vs BWEN Comparison

Compare MRSN & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • BWEN
  • Stock Information
  • Founded
  • MRSN 2001
  • BWEN N/A
  • Country
  • MRSN United States
  • BWEN United States
  • Employees
  • MRSN N/A
  • BWEN N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • MRSN Health Care
  • BWEN Industrials
  • Exchange
  • MRSN Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • MRSN 40.7M
  • BWEN 33.7M
  • IPO Year
  • MRSN 2017
  • BWEN N/A
  • Fundamental
  • Price
  • MRSN $0.32
  • BWEN $1.62
  • Analyst Decision
  • MRSN Buy
  • BWEN Strong Buy
  • Analyst Count
  • MRSN 3
  • BWEN 3
  • Target Price
  • MRSN $4.00
  • BWEN $4.50
  • AVG Volume (30 Days)
  • MRSN 2.3M
  • BWEN 71.8K
  • Earning Date
  • MRSN 05-15-2025
  • BWEN 05-13-2025
  • Dividend Yield
  • MRSN N/A
  • BWEN N/A
  • EPS Growth
  • MRSN N/A
  • BWEN N/A
  • EPS
  • MRSN N/A
  • BWEN 0.05
  • Revenue
  • MRSN $40,497,000.00
  • BWEN $143,136,000.00
  • Revenue This Year
  • MRSN N/A
  • BWEN $8.78
  • Revenue Next Year
  • MRSN N/A
  • BWEN $10.05
  • P/E Ratio
  • MRSN N/A
  • BWEN $32.62
  • Revenue Growth
  • MRSN 9.88
  • BWEN N/A
  • 52 Week Low
  • MRSN $0.26
  • BWEN $1.41
  • 52 Week High
  • MRSN $3.50
  • BWEN $4.65
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 41.87
  • BWEN 56.80
  • Support Level
  • MRSN $0.35
  • BWEN $1.49
  • Resistance Level
  • MRSN $0.44
  • BWEN $1.72
  • Average True Range (ATR)
  • MRSN 0.04
  • BWEN 0.07
  • MACD
  • MRSN -0.00
  • BWEN 0.00
  • Stochastic Oscillator
  • MRSN 8.48
  • BWEN 56.52

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: